Share
Journal Information
Issue
Vol. 19. Issue 6.Pages 583-700 (November - December 2020)
Editorial
For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis!
Kevork Minas Peltekian
Ann Hepatol. 2020;19:583-4
Open access
Opinions
Calling a stage-based treatment model for chronic liver diseases in China mainland
Xueqin Liu, Jian Xu
Ann Hepatol. 2020;19:585-9
Open access
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
Open access
Open Article
SARS-CoV-2 another kind of liver aggressor, how does it do that?
Sonia A. Lozano-Sepulveda, Kame Galan-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla
Ann Hepatol. 2020;19:592-6
Open access
Open Article
Concise reviews
Chemotherapy-associated steatohepatitis
Lucy Meunier, Dominique Larrey
Ann Hepatol. 2020;19:597-601
Open access
Role of CD98 in liver disease
Brandon S.B. Canup, Heliang Song, Hamed Laroui
Ann Hepatol. 2020;19:602-7
Open access
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
Open access
Original articles
The effect of liver test abnormalities on the prognosis of COVID-19
Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, Asli Ormeci, Bilger Cavus, Murat Kose, Osman Faruk Bayramlar, Gulcan Yildiz, ... Tufan Tukek
Ann Hepatol. 2020;19:614-21
Open access
Open Article
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
Rommel Zambrano-Huailla, Laura Guedes, Jose Tadeu Stefano, Arthur A. Arrais de Souza, Sebastián Marciano, Erika Yvamoto, Matheus Truccolo Michalczuk, Denise Siqueira Vanni, ... Claudia P. Oliveira
Ann Hepatol. 2020;19:622-6
Open access
A systematic review and meta-analysis of the COVID-19 associated liver injury
Yu Jun Wong, Malcolm Tan, Qishi Zheng, James Weiquan Li, Rahul Kumar, Kwong Ming Fock, Eng Kiong Teo, Tiing Leong Ang
Ann Hepatol. 2020;19:627-34
Open access
Open Article
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III
Mishal Reja, Michael Makar, Aayush Visaria, Daniel Marino, Vinod Rustgi
Ann Hepatol. 2020;19:635-40
Open access
Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases
Sebastián Marciano, Diego Arufe, Leila Haddad, Manuel Mendizabal, Adrián Gadano, Luis Gaite, Margarita Anders, Laura Garrido, ... Melisa Dirchwolf
Ann Hepatol. 2020;19:641-4
Open access
Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma
Huy Q Do, An B Luong, Deborah Bonazza, Cristina Bottin, Thao PT Doan, Long DC Tran, Nhung H Truong, Gianluca Tell, ... Caecilia HC Sukowati
Ann Hepatol. 2020;19:645-53
Open access
Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis
Yong Zhu He, Kun He, Rui Qin Huang, Ze Liang Wang, Shao Wei Ye, Li Wen Liu, Qi Jie Luo, Ze Min Hu
Ann Hepatol. 2020;19:654-61
Open access
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study
Federico Piñero, Marcos A. Thompson, Federico Diaz Telli, Juan Trentacoste, Carlos Padín, Manuel Mendizabal, Carla Colaci, Ariel Gonzalez Campaña, ... Marcelo Silva
Ann Hepatol. 2020;19:662-7
Open access
Cerebral hemodynamics in the non-alcoholic fatty liver
David Vidal-González, Guillermo Nahúm López-Sánchez, Luis Arturo Concha-Rebollar, Andrea Rodríguez-Herrera, Fernando Morales-Ramirez, Norberto Chávez-Tapia, Misael Uribe, Juan Alberto Nader-Kawachi, Natalia Nuño-Lámbarri
Ann Hepatol. 2020;19:668-73
Open access
Clinical practice guidelines
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares-da-Silva, Francisco Barrera, Carlos Benítez, Marlene Castellanos-Fernandez, Graciela Castro-Narro, Norberto Chavez-Tapia, ... Marco Arrese
Ann Hepatol. 2020;19:674-90
Open access
Case report
Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension
Mauro Giuffrè, Giorgio Bedogni, Cristiana Abazia, Flora Masutti, Claudio Tiribelli, Lory Saveria Crocè
Ann Hepatol. 2020;19:691-3
Open access
Letters to the editor
An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A
Vijay S.-Are, Lindsay Yoder, Niharika Samala, Lauren Nephew, Craig Lammert, Raj Vuppalanchi
Ann Hepatol. 2020;19:694-6
Open access
Body mass index and alcohol consumption are directly related with liver steatosis. Results from a prospective study of patients referred for hyperferritinemia
Agustín Castiella, Eva Zapata, Iratxe Urreta, Leire Zubiaurre, José Mª Alústiza, Pedro Otazua, José Ignacio Emparanza
Ann Hepatol. 2020;19:697
Open access
An acknowledgement
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
